NEW YORK, Dec. 4, 2018 /PRNewswire/ -- Optimal Synergy Between Leading-edge Computational Science and Therapeutics DevelopmentRead the full report: https://www.reportlinker.com/p05642139
The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry.A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approaches, are extensively enlighten drug discovery and development landscape for the effective treatment of diseases.AI is pursued to provide the best suited approach to leverage scientific literature, patient's omics-data and overall clinical data, to drive smart decisions.Read the full report: https://www.reportlinker.com/p05642139
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected]
US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
View original content:http://www.prnewswire.com/news-releases/artificial-intelligence-revolutionizing-the-pharmaceutical-industry-300760074.html
SOURCE Reportlinker
